Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

A decision is expected in the fourth quarter of 2025.

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

Jennifer Love Hewitt weight loss journey revolved around eating a healthy and balanced diet and working out regularly. Before we jump into her health and weight loss journey, let’s dive into her ...

(TNS) A Kentucky doctor faces up to three years in prison after admitting he sold patients a non-approved weight-loss drug. Matthew Tyler Lewis, 44, pleaded guilty Monday to a federal charge of ...

A new daily pill that suppresses the appetite has been shown to help patients lose weight in clinical trials. Participants, who were all obese and had type 2 diabetes, shed 8% of their body weight ...

No matter how much Berens exercised and dieted throughout her life, she couldn't lose weight. "I've always struggled with my weight," she said. "I've been up and down like a yo-yo for many years." ...

Eli Lilly on Thursday said its daily obesity pill met the company's goals in the first of several late-stage trials, helping patients with Type 2 diabetes lower their blood sugar and body weight ...